MARKETS
Markets

China SXT Pharmaceuticals Commences ~$9M Offering Of 4.5M Class Ordinary Shares At $3.20/Share

Jul 23, 2026 · 08:46 AM ET· updated 2h ago

China SXT Pharmaceuticals Inc. (NASDAQ:SXTC) (the "Company"), today announced that it has entered into a definitive securities purchase agreement with certain institutional investors for the purchase and sale of

Share
Why It Matters

China SXT Pharmaceuticals is selling new shares of its company to raise about $9 million from investors. When a company does this, it means they need cash for their business, so watch whether they use it wisely on things like medicine research or paying bills.

This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play

Last session drawn · prints held ~15 minutes · licensed exchange data

Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.

Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.